simvastatin has been researched along with Impaired Glucose Tolerance in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Chen, Y; Liu, J; Lu, Y; Pan, W; Yan, C; Zhang, C; Zhang, W | 1 |
| Babu, PP; Kapadia, B; Mandaliya, D; Misra, P; Muggalla, CS; Patel, S; Prajapati, B; Rapaka, N; Saxena, U; Seshadri, S | 1 |
| Cai, L; Sun, W; Xu, J; Xu, W; Yao, H; Zhou, Q | 1 |
| Bang, LE; Bundgaard, H; Dela, F; Hansen, CN; Helge, JW; Hey-Mogensen, M; Larsen, S; Nielsen, LB; Stride, N | 2 |
| Bode, WD; Simpson, RJ | 1 |
| Dela, F; Hansen, CN; Helge, JW; Larsen, S | 1 |
| Navas, P | 1 |
| Böhm, F; Hjemdahl, P; Malmström, RE; Pernow, J; Settergren, M | 1 |
| Böhm, F; Kalani, M; Pernow, J; Rydén, L; Settergren, M | 1 |
| Krysiak, R; Okopien, B | 3 |
| Pang, X; Qu, W; Wang, J; Zhang, W; Zhu, D; Zhu, X | 1 |
| Ichihara, K; Kanda, M; Kasai, T; Keimatsu, N; Satoh, K; Sun, F; Takaguri, A | 1 |
| Alexander, CM; Boccuzzi, SJ; Cook, JR; Herman, WH; Kjekshus, J; Musliner, TA; Pedersen, TR; Pyörälä, K | 1 |
4 trial(s) available for simvastatin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Topics: Aged; Anticholesteremic Agents; Azetidines; C-Reactive Protein; CD40 Ligand; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Ezetimibe; Female; Fibrinogen; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; P-Selectin; Platelet Aggregation; Simvastatin; Time Factors; Treatment Outcome | 2009 |
Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease.
Topics: Aged; Azetidines; Coronary Artery Disease; Diabetes Mellitus, Type 2; Ezetimibe; Female; Foot; Forearm; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Simvastatin; Skin; Ultrasonography | 2009 |
Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients.
Topics: Blood Glucose; C-Reactive Protein; Cytokines; Dyslipidemias; Female; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Simvastatin; T-Lymphocytes | 2011 |
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
Topics: Cardiovascular Diseases; Cost-Benefit Analysis; Diabetic Angiopathies; Double-Blind Method; Fasting; Female; Glucose Intolerance; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Scandinavian and Nordic Countries; Simvastatin; Survival Rate | 1999 |
12 other study(ies) available for simvastatin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Sarcodon aspratus polysaccharides ameliorated obesity-induced metabolic disorders and modulated gut microbiota dysbiosis in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Basidiomycota; Diet, High-Fat; Dietary Supplements; Gastrointestinal Microbiome; Glucose Intolerance; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Liver; Metabolic Diseases; Mice; Obesity; Oxidative Stress; Polysaccharides; Simvastatin; Weight Gain | 2020 |
Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model.
Topics: Animals; Atorvastatin; Diet; Disease Models, Animal; Fatty Acids; Feeding Behavior; Gene Expression Regulation; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Insulin; Muscles; Rats; Signal Transduction; Simvastatin; Sucrose | 2019 |
Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Child; China; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypolipidemic Agents; Magnesium; Male; Middle Aged; Prediabetic State; Simvastatin; Young Adult | 2013 |
Reply: To PMID 23287371.
Topics: Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitochondria, Muscle; Muscle Fibers, Skeletal; Simvastatin; Ubiquinone | 2013 |
Simvastatin effects on skeletal muscle: study design and validity.
Topics: Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitochondria, Muscle; Muscle Fibers, Skeletal; Simvastatin; Ubiquinone | 2013 |
Reply: To PMID 23287371.
Topics: Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitochondria, Muscle; Muscle Fibers, Skeletal; Simvastatin; Ubiquinone | 2013 |
The way to determine coenzyme Q.
Topics: Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitochondria, Muscle; Muscle Fibers, Skeletal; Simvastatin; Ubiquinone | 2013 |
Haemostatic effects of simvastatin in subjects with impaired glucose tolerance.
Topics: Adult; Aged; Blood Glucose; Female; Glucose Intolerance; Glucose Tolerance Test; Hemostasis; Humans; Hypercholesterolemia; Male; Middle Aged; Simvastatin | 2011 |
Different effects of simvastatin on ex vivo monocyte cytokine release in patients with hypercholesterolemia and impaired glucose tolerance.
Topics: Blood Glucose; C-Reactive Protein; Cholesterol; Cytokines; Female; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Inflammation; Male; Middle Aged; Monocytes; Simvastatin; Triglycerides | 2010 |
Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Fat Distribution; Cholesterol; Dietary Fats; Disease Models, Animal; Flavonoids; Glucose Intolerance; Hippophae; Hypercholesterolemia; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Mice; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Seeds; Simvastatin; Triglycerides | 2011 |
Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.
Topics: Blood Glucose; Case-Control Studies; Cell Respiration; Electron Transport; Electron Transport Complex I; Electron Transport Complex II; Glucose Intolerance; Glucose Tolerance Test; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; Middle Aged; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle, Skeletal; Oxidative Phosphorylation; Simvastatin; Ubiquinone | 2013 |
HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Pravastatin; Pyrroles; Rats; Rats, Wistar; Simvastatin | 2005 |